Results 21 to 30 of about 1,488,405 (299)

Potential biomarkers of ductal carcinoma in situ progression

open access: yesBMC Cancer, 2020
Background Ductal carcinoma in situ is a non-obligate precursor of invasive breast carcinoma and presents a potential risk of over or undertreatment. Finding molecular biomarkers of disease progression could allow for more adequate patient treatment.
Raquel Spinassé Dettogni   +17 more
doaj   +1 more source

Invasive Lobular Carcinoma of Breast with Extracellular Mucin: A Novel Entity

open access: yesJournal of Medical Sciences and Health, 2023
Invasive carcinoma of no special type (NST) or ductal carcinoma is the most common type of invasive breast cancers. Invasive lobular carcinoma (ILC) is the most common special variant amongst breast cancers that lacks some of the common features
Md. Samim Iqbal   +5 more
doaj   +1 more source

A new model for ductal carcinoma in situ suggests strategies for treatment [PDF]

open access: yes, 2002
Human ductal carcinoma in situ (DCIS) of the breast is now diagnosed quite frequently, due largely to the introduction of mammographic screening. It has been shown in a cell culture system that activation of c-erbB-2, but not the epidermal growth factor ...
Gullick, William J.
core   +1 more source

Evaluation of glutathione S-transferase Pi in non-invasive ductal carcinoma of breast [PDF]

open access: yes, 2015
Glutathione S-transferase Pi (GST P) has been reported to be a marker of dysplastic lesions. For this reason expression of GST P by intraduct breast carcinoma was evaluated by immunohistochemistry. Thirty-seven of 92 carcinomas (40%) were GST P positive.
Bellamy, C O, Harrison, D J
core   +2 more sources

Invasive Lobular Carcinoma of the Breast with Extracellular Mucin- A New Rare Variant [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2015
Historically, extracellular mucin secretion is by default a feature of ductal carcinoma. Lobular carcinoma is known to be associated with only intracytoplasmic mucin production and signet ring cells.
Vaibhav Bhika Bari   +2 more
doaj   +1 more source

A comparison of the clinical outcomes of patients with invasive lobular carcinoma and invasive ductal carcinoma of the breast according to molecular subtype in a Korean population

open access: yes, 2021
Breast cancer-specific survival; Invasive ductal carcinoma; Invasive lobular carcinoma; Molecular subtype; Overall ...
문병인
core   +1 more source

Unusual Metastasis of Lobular Carcinoma of the Breast

open access: yesHaseki Tıp Bülteni, 2018
Invasive lobular carcinoma is the second most common type of invasive breast cancer accounting for approximately 5-10% of all invasive breast carcinomas. The metastatic patterns of lobular and ductal carcinomas are significantly different.
Songül Peltek Özer, Saime Gül Barut
doaj   +1 more source

The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a National Cancer Database Study

open access: yesnpj Breast Cancer, 2021
When molecular testing classifies breast tumors as low risk but clinical risk is high, the optimal management strategy is unknown. One group of patients who may be more likely to have such discordant risk are those with invasive lobular carcinoma of the ...
Mary Kathryn Abel   +8 more
doaj   +1 more source

Expression of tumour transcription factor GLI1 in canine mammary tumours tissue

open access: yesVeterinary Medicine and Science, 2022
Background Mammary tumor is one of the most common diseases of canine in pet clinics. Objectives This study investigates the distribution and expression of the tumor transcription factor GLI1 and the downstream proteins, Bmi1 and Sox2, in canine mammary ...
Penggang Liu   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy